Longeveron Inc. (LGVN) Insider Trading -- Recent Executive & Director Transactions
19 insiders reported 72 Form 4 transactions for Longeveron Inc. (LGVN) over the past 18 months (most recent 2026-10-05). Recent activity: Lehr Paul T (General Counsel, Secretary) Sell 2,253 shares, Blass Devin (CTO & SVP of CMC) Sell 2,520 shares, Agafonova Nataliya (Chief Medical Officer) Sell 2,913 shares, Jhaveri Nirav S. (Chief Financial Officer) Sell 742 shares, Willard Stephen H (Chief Executive Officer) Sell 1,987 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Lehr Paul T | General Counsel, Secretary | Sell | 2,253 | $5,835 |
| 2026-10-05 | Blass Devin | CTO & SVP of CMC | Sell | 2,520 | $6,527 |
| 2026-10-05 | Agafonova Nataliya | Chief Medical Officer | Sell | 2,913 | $7,545 |
| 2026-10-05 | Jhaveri Nirav S. | Chief Financial Officer | Sell | 742 | $1,922 |
| 2026-10-05 | Willard Stephen H | Chief Executive Officer | Sell | 1,987 | $5,146 |
| 2026-08-25 | Jhaveri Nirav S. | Chief Financial Officer | Buy | 300,000 | $0 |
| 2026-08-21 | Cann Leah Rush | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Ascheim Deborah | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Soffer Rock | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Lehr Paul T | General Counsel, Secretary | Buy | 286,000 | $0 |
| 2026-08-21 | Ungaro Ursula | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Hare Joshua | Chief Scientific Officer | Buy | 286,000 | $0 |
| 2026-08-21 | Agafonova Nataliya | Chief Medical Officer | Buy | 286,000 | $0 |
| 2026-08-21 | Hajjar Roger Joseph | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Blass Devin | CTO & SVP of CMC | Buy | 286,000 | $0 |
| 2026-08-21 | Paletta George A. Jr. | Director | Buy | 36,000 | $0 |
| 2026-08-21 | Desai Arjun JJ | Director | Buy | 36,000 | $0 |
| 2026-07-08 | Hare Joshua | Chief Scientific Officer | Buy | 600,000 | $0 |
| 2026-07-06 | Willard Stephen H | Chief Executive Officer | Sell | 18,046 | $13,157 |
| 2026-07-06 | Agafonova Nataliya | Chief Medical Officer | Sell | 22,505 | $16,408 |
| 2026-07-06 | Locklear Lisa | Chief Financial Officer | Sell | 22,505 | $16,408 |
| 2026-07-06 | Blass Devin | CTO & SVP of CMC | Sell | 15,808 | $11,526 |
| 2026-07-06 | Lehr Paul T | General Counsel, Secretary | Sell | 13,143 | $9,583 |
| 2026-05-05 | Lehr Paul T | General Counsel, Secretary | Buy | 250,000 | $0 |
| 2026-05-05 | Blass Devin | CTO & SVP of CMC | Buy | 250,000 | $0 |
Source: SEC Form 4 filings · as of 2026-10-05